BetterLife Pharma BETRF
OTC BETRF
$0.17 +0.02 (+10.39%)
As of: Oct 21, 2026 · 12:20 PM EDT

BetterLife Pharma (BETRF) Current Deferred Revenue (2018 - 2020)

Updated

BetterLife Pharma (BETRF) posted Current Deferred Revenue of $34,505 for fiscal Q3 2021 (quarter ended Oct 31, 2020).

Analysis

BetterLife Pharma (BETRF) Current Deferred Revenue (2018 - 2020) Analysis & Trends

At the end of FY2019 (ended Jan 31, 2019), BetterLife Pharma's Current Deferred Revenue came in at $121,087.

  • The fiscal Q3 2021 figure stands as the highest quarterly Current Deferred Revenue since fiscal Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.00 Bn 1,140.58 Bn 19.71 Bn
2 Johnson & Johnson 639.12 Bn 557.64 Bn 17.26 Bn
3 AbbVie 502.23 Bn 475.34 Bn 12.70 Bn
4 Merck 375.29 Bn 329.67 Bn 12.21 Bn
5 Novartis Ag 302.99 Bn 266.98 Bn 11.24 Bn
6 Astrazeneca 268.68 Bn 242.36 Bn 12.86 Bn
7 Amgen 242.24 Bn 197.64 Bn 7.24 Bn
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn
10 BetterLife Pharma 24.95 Mn 24.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2020 34,262.09
Jan 31, 2019 120,027.39
Oct 31, 2018 120,000.00
API Access

BetterLife Pharma Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BETRF&period=max&api_key=YOUR_API_KEY